Peer Review History

Original SubmissionJune 21, 2022
Decision Letter - Fares Alahdab, Editor

PONE-D-22-17745What are the top priorities of patients and clinicians for the organization of primary cardiovascular care in Quebec? A modified e-Delphi studyPLOS ONE

Dear Dr. Del Grande,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

ACADEMIC EDITOR:Thank you. We are interested in accepting your submission after the minor comments below from the reviewer are addressed. 

Please submit your revised manuscript by Dec 19 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Fares Alahdab

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

3. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The paper by Del Grande and coauthors covers an important topic and is both interesting and well written. The Delphi process that they used was appropriate to the task at hand.

One can argue whether the findings were surprising. Patients will absolutely want to be seen in a timely fashion by physicians who are personable, communicative, well-organized and up-to-date in their field, all of which I have sought when I have been a patient. The lower priority given by study patients for healthy lifestyle and prevention activities at their primary health care clinics might surprise some clinicians. But patients have other sources for such information; and I could see where, with limited time to see their health care provider, they would wish to focus on the matter at hand rather than hear (yet again) why they need to eat better and exercise more.

Nonetheless, even if at least some of the results might seem expected, the fact that there are divergences of opinion between patients and providers around organizational priorities (among other dimensions) -- ones that are not invariably self-evident -- emphasizes how important such work is to inform clinic and program planning. While the authors list as a limitation the fact that findings relating to the Quebec health care environment might incompletely translate to other settings, I rather suspect that some of the central themes will be broadly noted elsewhere.

Based on this and similar work, it seems that periodically revisiting whether patients and physicians are on the same page should be mandated, especially under circumstances where changes in process or services are being considered by health care providers. Indeed, the authors alluded to the fact that their study was conducted at the time that the COVID infection was especially rampant and disruptive. One of the side effects of the disease has been to put the practice of telemedicine into overdrive. In person clinic visits are returning, but a sizeable number of patient-clinician interactions in my cardiology subspecialty group will continue to be virtual. The work by Del Grande and colleagues shows that we should take no assumptions for granted. In my experience, televideo consultations seem generally well received, especially for routine check-ups of stable patients. But rather than make presumptions, my colleagues and I might do well to survey our patients to know how they feel and have then inform us on how we might do better.

I really do not have any significant criticisms to offer on content or writing style.

Reviewer #2: This is a well-designed and well written study, which I have read with great interest. I have some comments.

1) Can you give any reasons why six FMG clinics declined to participate? Line 131-32.

2a) Were there any changes to the questionnaires as a result of the pre-testing (before round one)?. Line 188-189.

2b) And what professions did the clinicians in the pre-test group have?

3a) Is there any rationale why the limits of 6-7 for rating and correspondingly ranking the item in the top half of its thematic list was set? Line 244-245

3b) In what way are these limits comparable?

4) Line 273, was the five nurses registered nurses or assistant nurses? And what profession had the allied health professional?

5) Among the participating patients almost all had a post-secondary education. I think readers should interpret the result with this in mind, why I suggest adding this as a limitation.

6) Add a footnote below table 1 indicating that patients encompass both patients and faculty patient partners. Line 292.

7a) Line 294-295, was the number of submitted aspects and the synthesized items equally balanced between patients and clinicians?

7b) Also, it reads: average of 4 per panelist, can this be presented for each group (patient, clinicians) also including min and max?

8) Line 361, add percentages along with the p-value 0.014

9) Line 387, the study by Wensing et al. reports patients’ involvement in decisions as one of the most important aspects, which is not so clear from your results. Or which of your identified items and themes reflect that? Please elaborate.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

As stated in the updated cover letter, we appreciate the time and effort that the editor and reviewers have dedicated to providing feedback on our manuscript and are grateful for the insightful comments on and valuable improvements to our paper. We have been able to incorporate changes to reflect all of the suggestions made by the reviewers (see Response to reviewers file). We have also addressed the additional requirements requested by the editor to the best of our understanding and have uploaded the updated files.

Attachments
Attachment
Submitted filename: Response to reviewers.docx
Decision Letter - Fares Alahdab, Editor

What are the top priorities of patients and clinicians for the organization of primary cardiovascular care in Quebec? A modified e-Delphi study

PONE-D-22-17745R1

Dear Dr. Del Grande,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Fares Alahdab

Academic Editor

PLOS ONE

**********

Formally Accepted
Acceptance Letter - Fares Alahdab, Editor

PONE-D-22-17745R1

What are the top priorities of patients and clinicians for the organization of primary cardiovascular care in Quebec? A modified e-Delphi study

Dear Dr. Del Grande:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Fares Alahdab

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .